Who We Are
Limitless is a team of lower middle market and early stage independent sponsors supporting deep technology solutions in healthcare and climate technologies. As of Q4-2023, our investments (28 and counting) have positively impacted 105,000+ lives and saved over 100,000+ Metric Tons of Carbon Dioxide since 2017.
Our goal is to improve 500,000 lives and save 100M Metric Tons of CO2 by 2030.
Our (USA) domestic investment strategy thematically focuses on two areas Healthcare and Climate. For both areas, we focus on the Continuum of Solitions for each unique aspect of the supply chain. We believe in each category (outlined below), there are likely only a few winners. These winners take most of the market share, and are our target companies. Therefore we our thesis driven investment philosophy seeks to find companies whose solutions range across the Continuum ranging from prevention/reduction through innovation and ultimately long-term well-being/sustainability.
For Healthcare, one example is outlined by the Determinants of Health (DoH) modeled by the Center for Disease Control defines DoH as the following [1]:
genetics,
behavior,
environmental and physical influences,
medical care and social factors
For Climate, a few industries examples we have supported in the past include:
Agriculture,
Infrastructure,
Transportation,
Co/Tri/Quad-Generation.
Throughout all deals, we believe that our strategy provides idiosyncratic, uncorrelated (but inter-related) returns on our risk. Therefore the firm has historically supported companies who are self supporting and may provide synergies to another portfolio company. This effort, supports a fly-wheel effect in both the income statement and generates positive impact (i.e. detoxing humans from opioid addiction). For example:
Prevention/Reduction through community enabled technology or sequestration solutions.
Innovation through Life Sciences (i.e: biotech, medical device class I,II) and new forms of distributed energy generation.
Access to Care/Solutions through Insurance, or financing.
Distribution of Treatment (i.e: Healthcare Business Services) or improvement solutions (i.e: Engineering, Procurement, Maintenance)
Long Term Health/Net Zero through Real Estate, Food as Medicine and Skill Development.
Generally, but not explicitly, we focus our time energy and effort on deals within the fields of Mental Health. Some indications of deals we have funded in the past include:
Healthcare:
Depression
Suicidal Ideation
Bi-Polar
Substance Use Disorder (Alcohol, Opioids, Cocaine & Nicotine)
Process Addictions (Obesity, Gambling, Gaming)
Covid-19
Parkinsons
Climate:
Aviation & Transportation
Innovation Enginering & Materials Science
Agriculture
Industrial Circular Economy (waste streams to feedstocks)
While we have strong opionions, they are loosely held. As such, we reserve the right to change our mind in light of new information. In general, we have supported companies with the following high-level investment criteria:
Market:
A significant Total Addressable Market which is growing with a significant unmet need.
Solution:
A unique defensible value proposition with many hard (i.e: IP) and soft moats (business partnerships/exclusivity).
Economics:
A scalable unit economic model.
Team:
Led by a team of individual experts who have successfully managed (exited a company through sale/aquisition) the entrepreneurial journey (ideally together). We seek open minded teams with strong opinions, loosely held.
Resources:
Teams backed by a network of capital partners and domain expert relationships with tasset knowledge. Specifically, people who can support business execution with talent, capital and business development deals.
As a team seeking partners, we are relentlessly focused on mutual success. Therefore, we often role up our sleeves, take board seats, advisory positions or CxO roles while leveraging our network to drive unparalleled access, insights and operational execution.
From a company stage perspective, we have a barbell allocation strategy. which has historically deployed a large minority of our capital to Seed and Series A companies and a large marjority to late stage/Pre-IPO companies. Our median time to return on the principal on invested capital is 4.25 years. Some of our investors have net DPI’d as much as 2.4x during that period.
We practice radical responsibility with our capital, time and effort. Our values prioritize wealth preservation, alpha maximization and most importantly, creating impact which involves systems level change. We believe in value-based/climate outcomes for patients and our planet as part of our critical path investment criteria. We believe in win-win solutions which create alignment across the ecosystems, from patients/customers to payers/clinicians all the way to the limited partners.
Thank you for learning about us, we would be delighted to hear from you.
Sincerely,
Limitless Ventures Management Team
Mantra: Healthy People and a Healthy Planet
Email: info@limitlessventures.us